This presentation was prepared by MeaTech Ltd. (the “Company”), and is given to you only for the provision of concise information for the sake of convenience, and may not be copied or distributed to any other person. The data and information included in this presentation should not be interpreted as advice and should not be relied on for any purpose. Such data and information should not be copied or used except as expressly permitted in writing. This presentation does not purport to be comprehensive or to contain any and all information which might be relevant in connection with the making of a decision on an investment in securities of the Company. No explicit or implicit representation or undertaking is given by any person regarding the accuracy or integrity of any information included in this presentation. In particular, no representation or undertaking is given regarding the realization or reasonableness of any forecasts regarding the future chances of the Company. To obtain a full picture of the activities of the Company and the risks entailed thereby, see the full immediate and periodic
reports filed in connection with the Company with the Israel Securities Authority and the Tel Aviv Stock Exchange Ltd., including warnings regarding forward-looking information, as defined in the Securities Law, 5728-1968, included therein. The forward-looking information in the presentation may not materialize, in whole or in part, or may materialize differently than expected, or may be affected by factors that cannot be assessed in advance. For the avoidance of doubt, it is clarified that the Company do not undertake to update and/or modify the information included in the presentation to reflect events and/or circumstances occurring after the date of preparation of the presentation. This presentation is not an offer or invitation to buy or subscribe for any securities. This presentation and anything contained herein are not a basis for any contract or undertaking, and are not to be relied upon in such context. The information provided in the presentation is not a basis for the making of any investment decision, nor a recommendation or an opinion, nor a substitute for the discretion of a potential investor.
02OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
FORWARD LOOKING STATEMENT
World consumption of proteins, especially from meat products, continues to rise.
The accelerated demand for animal protien creates massive environmental, health, financial and ethical problems.
Meat Tech is developing an alternative to conventional farming that circumvents harming animals: clean farming through an industrial cultured meat process, combined with 3D printing technology.
03OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
INTRODUCTION
+ As the world population increases and becomes wealthier, global demand for meat only grows.
+ Today’s farming technologies cannot meet future demand.
5OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
500 million
400 million
300 million
200 million
100 million
1961 1980 2000 2020 2040 2060
Eggs Sheep and goat
Beef and Buffalo
Pigmeat
Poultry
Global meat project ion to 2050
DEMAND FOR MEAT IS ON THE RISE
Source: UN Food and Agriculture Organization (FAO)
07OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
THE ENVIRONMENTAL PROBLEM
+ 8% of the world's water is used for raising livestock
+ 33% of croplands are used for animal feed
production.
+ At least 18% of the greenhouse gases entering
the atmosphere can be traced back to the livestock industry.
2. Problem
The meat industry is highly pol lut ive
33%18%8%
08OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
Animals Slaughtered annual ly (US)
SHEEP
CATTLE
DUCKS
TURKEYS
CHICKENS
PIGS
7,781,609,673
235,987,266
36,882,737
24,160,006
6,990,150
112,987,266
THE ETHICAL PROBLEM
+ Hormones and antibiotics are used legally, and illegally, in animal husbandry to manage animal growth and health (see avian flu, swine flu etc.)
09OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
THE NUTRITIONAL PROBLEM Industr ial farming is a potential health/healthcare issue
56 days of growth
11OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
THE GREAT HORSE MANURE CRISIS OF 1894 Over-use of animals has been replaced by technology before
CULTURED CELLS 3D PRINTINGSTRUCTURED MEAT
13OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
MEAT TECH’S CELLULAR 3D
An umbilical cord sample is taken without harming
the animal
A cell line isdeveloped forcontinued cellreproduction
Cells aredifferentiated into inks with different cell types such as
fat and muscle
The cell types and scaffolding
are accurately 3Dbioprintedto create the foundations for a true cut of meat
The 3D printed structures are
placed inincubators to
mature and grow
The finished'print' of meatis frozen andpackaged for
shipping
14OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
Initial cell sample Bioreactor growth Cellular ink 3D bioprinting Incubation Freezing & Packing
MEAT TECH A FULL TECHNOLOGY STACK
15OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
MEAT TECH’S CELLULAR 3D
Muscle Fat Structure Protein
Bioreactors Incubation
16OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
THE INDUSTRIAL PROCESSTHE INDUSTRIAL PROCESSFrom cel ls to steaks: Manufacturing at scale
3D Bioprinter
17OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
MTC0001USP
MTC0002USP
MTC0001USP
MTC0005USP
MTC0005USP
Physical Manipulation of Cultured T issue
Harvesting Bovine Embryonic Inner Cell Mass Cells
Bioprinter Print Head
Bioprinter Print Head
Cultured Edible Meat Fabrication Using Bioprinting
Intel lectual Property
MEAT TECH’S IP
62,903,879
62,871,438
62,934,582
62,985,463
63,035,904
Physical Manipulation of Cultured T issue
Harvesting Bovine Embryonic Inner Cell Mass Cells
Bioprinter Print Head
Growth Support For Cell Culture
Cultured Edible Meat Fabrication Using Bioprinting
Intel lectual Property
19OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
THE NEW PROTEIN COMPETITIVE LANDSCAPE
3D PRINTED STEAK
CULTURED MEAT
NOT 3D PRINTED
PLANT BASED
20OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
By 2040, conventional meat’s market share wi l l be halved
Source: United Nations, World Bank, Expert interviews; A.T Kearney analysis
1 Numbers are rounded to hundred billions $US
THE PROTEIN MARKET IS CHANGING
+3%
22OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
SHARON F IMA
Sharon is an entrepreneur wi th over 20 years of
exper ience in the pr int ing industry. Sharon was the
founder and CTO of Nano Dimension (NNDM) and
spearheaded the development of a complete desk-
top 3D pr int ing system for mult i layer PCBs. Pr ior to
NNDM, Sharon was the R&D Integrat ion manager at
XJet and an R&D team leader at HP Indigo.
DANNY AYALON
Mr. Ayalon is the former Israe l i Ambassador to
the Uni ted States and Deputy Min ister of Fore ign
Affa i rs, Member of Knesset and advisor to three
pr ime min isters. Mr. Ayalon is the co-founder and
Chairman of S i lver Road Capita l Ltd.
CEOSTEVE LAVIN
Mr. Lav in serves as V ice Chairman of OSI Group,
LLC, a pr ivate ly he ld company and a g lobal suppl ier
of va lue-added food and meat products. Mr. Lav in
is the Pres ident of Lav in & Gedvi l le , a bout ique
law f i rm. Mr. Lav in is d i rector, genera l counsel and
advisor to Germin8 Ventures, LLC, and co-founder
and di rector of S i lver Road Capita l , Ltd. , a f inancia l
and consul t ing f i rm.
CHAIRMAN DIRECTOR
AMB.
TEAM
23OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
CHEMISTRYSHLOMO MAGDASSI
PROF.PROF.
Prof Shlomo Magdassi is a Professor of Chemistry,
at the Casal i Center for Appl ied Chemistry, the
Inst i tute of Chemistry and the Center for Nanoscience
and Nanotechnology at the Hebrew Univers i ty of
Jerusalem, Israe l . Prof . Magdassi holds the Enr ique
Berman Chair in Solar Energy. His research focuses
on col lo id sc ience, part icu lar i ly on the format ion,
formulat ion, and appl icat ion of novel micro and
nanopart ic les.
BIOLOGYTAL DVIR
Prof . Dv i r obta ined h is degrees in Biotechnology
Engineer ing f rom Ben-Gur ion Univers i ty of the Negev
in Israe l . Prof . Dv i r cont inued h is postdoctora l
studies in the laboratory of Prof . Robert Langer in
the Department of Chemical Engineer ing at MIT.
Prof . Dv i r was recru i ted by the Department of
Biotechnology and the center for Nanotechnology
of Te l Av iv Univers i ty to establ ish the Laboratory for
T issue Engineer ing and Regenerat ive Medic ine.
TEAM
24OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
MEAT ALTERNATIVES PATH
Organoleptic Properties
Evolution
Today
Plant Based
Hybrid Meat
Cultured Ground Meat
3D Printed cultured meat
+
+
Plant Based
Cultured Fat
Cultured Meat
3D Bio - Printer
MEAT TECH'SSUBSIDIARIES
25OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
BUSINESS MODEL
+ As the cellular agriculture sector matures, Meat Tech's technology will be attractive to the entire meat value chain.
+ Meat Tech will license its end-to-end cultured meat technology process to food producers.
+ Meat Tech and subsidiaries will generate revenue from a variety of cultured meat products.
CAPEX
REVENUE REVENUE FROM
ROYALTIES
MEAT TECH'SSUBSIDIARYCOMPANIES
+
26OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
MEAT TECH 3D REVENUE STRATEGY
3D Print ing Technology Licensing
Cultured Meat Manufactur ing Site
SUBSIDIARYCOMPANIES
Royalt ies Generated from Hybrid Products
Animal Cel l Growth Factors and Media Production Site
PORK FISH POULTRY BEEF
IN R&D PROCESS IN THE WORKPLAN
27OCTOBER 2020
© ALL RIGHTS RESERVED www.meaTech3d.com
MEAT TECH 3D STRATEGY
A manufacturing site for the production of pro-
teins and growth factors required for altenative
protien production
Chick&Tech will develop poultry cell lines for
the alternative protien industry.
LABOFISH will develop fish cell lines and products for the
alternative protein industry
Goose and chicken fat production for
the alternative meat industry
A company will develop plant strains to express growth factors and pro-
teins required to produce cultured meat.
Buy 100% 100% 100% 50/50 Buy 100%
Under LOI and investmentIn process
Top Related